New system refines classification of cytogenetic abnormalities at time of response assessment and their clinical significance
Single-cell next-gen sequencing showing promise to improve sensitivity of MRD testing
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Advertisement